Skip to main content
WP

www.pulsecare.cn

Shenzhen Maiwei Medical Technology develops and manufactures minimally invasive medical devices utilizing multi-modal energy platforms, including pulsed electric field and ultrasound technologies, for treating conditions such as cardiac electrophysiology and liver tumors. Their products aim to improve clinical outcomes and patient safety by providing effective treatment options for atrial fibrillation, liver tumors, and intractable hypertension.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Current treatments for conditions like atrial fibrillation, liver tumors, and intractable hypertension often involve invasive procedures with potential complications and limited effectiveness. Existing medical devices may not offer the precision and multi-modal energy options needed for optimal therapeutic outcomes.

Solution

Shenzhen Maiwei Medical Technology develops minimally invasive medical devices that utilize multi-modal energy platforms, including pulsed electric field (PEF), ultrasound, radiofrequency, and plasma technologies, to address these challenges. Their devices aim to improve clinical outcomes and patient safety by providing precise and effective treatment options for a range of conditions. By combining multiple energy modalities, Maiwei's technology allows for targeted tissue ablation and neuromodulation with reduced risk of off-target effects. The company's product pipeline includes devices for cardiac electrophysiology, liver tumor ablation, and renal denervation for hypertension.

Target Audience

The primary target audience includes interventional cardiologists, interventional radiologists, and other physicians specializing in minimally invasive procedures for treating cardiac arrhythmias, liver tumors, and hypertension.

Features

  • Multi-modal energy platform capable of delivering pulsed electric field (PEF), ultrasound, radiofrequency, and plasma energy
  • nsPFA cardiac electrophysiology ablation system for treating atrial fibrillation
  • Ultrasound-based renal denervation (RDN) system for intractable hypertension
  • Multi-modal tumor ablation system for liver tumors
  • Minimally invasive design for reduced patient trauma and faster recovery
  • Precise energy delivery for targeted tissue ablation and neuromodulation
This profile is AI-generated and may contain inaccuracies.